Grapon delivers focused intelligence engagements across the clinical, commercial and regulatory dimensions of pharmaceutical and biotech competition.
We investigate how competitors are developing, positioning and preparing their assets.
Targeted interviews designed around the questions that remain unanswered after secondary research.
We connect trial activity and emerging evidence with expert interpretation and competitive implications.
We examine how markets, customers and competitors may shape commercial decisions.
We track regulatory developments and use expert perspectives to clarify competitor filing and approval strategy.
Structured monitoring keeps teams current between major intelligence projects.
Projects can be scoped around a single question, a major catalyst or an ongoing intelligence need.
A focused 2–3 week engagement for a defined set of KIQs and targeted expert interviews.
A broader 3–5 week engagement for a strategic competitor, asset or market question.
Monthly or quarterly monitoring with selected primary research and deep dives around key catalysts.
We can start with the question, not a predetermined research package.